APO Research

APO RESEARCH · REPORT

Oral Health Supplements

Oral health supplements are ingestible, non-prescription nutrition products intended to act within the oral cavity and along the oro-mucosal–systemic axis as an adjunct to evidence-based dental care. The category encompasses capsules, powders, liquids, orodispersible tablets, lozenges, chewing gums, and oromucosal films formulated to shift biofilm ecology toward commensal dominance, improve enamel mineral homeostasis, and modulate gingival–periodontal inflammatory tone. Topical cosmetics such as toothpastes and rinses are outside scope, and fluoride drugs or any product asserting disease treatment are regulated separately. In all major jurisdictions these products are governed under dietary or health-food frameworks with structure/function positioning and post-market surveillance rather than pre-market drug approval.

Product & engineering

Understand the product.

Oral health supplements are ingestible, non-prescription nutrition products intended to act within the oral cavity and along the oro-mucosal–systemic axis as an adjunct to evidence-based dental care. The category encompasses capsules, powders, liquids, orodispersible tablets, lozenges, chewing gums, and oromucosal films formulated to shift biofilm ecology toward commensal dominance, improve enamel mineral homeostasis, and modulate gingival–periodontal inflammatory tone. Topical cosmetics such as toothpastes and rinses are outside scope, and fluoride drugs or any product asserting disease treatment are regulated separately. In all major jurisdictions these products are governed under dietary or health-food frameworks with structure/function positioning and post-market surveillance rather than pre-market drug approval.

Formulation strategy is mechanism-led. Microbiome-directed designs use strain-identified probiotics or postbiotics with optional prebiotic substrates to suppress cariogenic and periodontopathogenic taxa, inhibit adhesion and co-aggregation, and stabilize intra-oral pH; dosage forms prioritize residence time through lozenges, gums, or thin films to maximize mucosal contact. Remineralization support raises salivary calcium-phosphate supersaturation and buffering capacity using bioavailable calcium and phosphate sources co-formulated with vitamin D and, where appropriate, vitamin K₂; arginine or xylitol may be included to leverage the arginine deiminase pathway and non-fermentable sweetening. Anti-inflammatory and antioxidant complexes, typically combining omega-3 EPA/DHA, coenzyme Q10, zinc, vitamin C, and selected polyphenols, aim to temper local mediators and support collagen synthesis in periodontal tissues. Halitosis control relies on odor-binding ions such as zinc and compatible microbiome modulators to reduce volatile sulfur compounds measured instrumentally.

Dosage-form engineering determines clinical yield. Orodispersible and mucoadhesive matrices based on HPMC, polycarbophil, or carbomers are tuned for wetting, controlled erosion, and adhesion to non-keratinized mucosa; oromucosal films are cast for uniform content, defined tear strength, and disintegration within targeted residence windows. Probiotic viability is protected through low-water-activity systems, glass-forming carriers, and oxygen control, with viable counts specified at end-of-shelf-life rather than at manufacture. Flavor and sweetening systems are chosen for dental compatibility, favoring xylitol or mannitol over fermentable sugars; compression, lubrication, and moisture management are balanced to prevent capping and to maintain friability in lozenges. Delivery performance is verified with appropriate disintegration and dissolution testing, residence-time studies in model saliva, and, for gums, mass-balance release methods.

Ingredient quality is defined to pharmacopeial or validated internal standards. Vitamins and minerals are declared by chemical form and potency; omega-3 concentrates specify EPA+DHA content together with oxidation indices; polyphenol sources are fingerprinted for marker compounds and screened for adulteration; probiotics are identified to strain by genetic or proteomic methods with contaminant screening and, where relevant, antibiotic-resistance profiling. Elemental contaminants such as arsenic, cadmium, lead, and mercury are controlled to stringent limits; microbial quality follows non-sterile supplement specifications with absence testing for relevant pathogens. Allergen and excipient declarations reflect regional labeling rules, including potential dairy or soy carriers in probiotic systems.

Manufacturing operates under current good manufacturing practice for dietary supplements. Quality-unit oversight, master manufacturing records with controlled changes, supplier qualification and full material traceability, validated analytical methods, in-process controls, and finished-product specifications for identity, strength, purity, and composition are mandatory. Out-of-specification investigations and corrective-and-preventive actions precede quality disposition. Stability programs combine accelerated and real-time studies to justify expiry; acceptance criteria cover potency retention, viable counts where applicable, organoleptics, and microbiological status. Packaging is selected for moisture and oxygen barrier performance appropriate to climate risk—Alu–Alu blisters, induction-sealed HDPE with desiccant canisters, or composite pouches with scavengers—supported by sorbent sizing calculations and transit simulations.

Claims, labeling, and surveillance are designed into the product at concept stage. In the United States, products carry substantiated structure/function claims such as “supports healthy gums,” bear the dietary-supplement disclaimer, and maintain serious adverse-event reporting; disease claims are excluded. In the European Union, supplements are defined under food-supplement law and all nutrition and health claims use authorized or qualified wording; novel ingredients may require novel-food clearance. In China, the category is managed as health foods with registration or filing and defined function catalogues; in Japan, many products follow FOSHU or Foods with Function Claims routes with pre-market notification and public evidence summaries. Across markets, truthful labeling, transparent quantitation of actives, and documented claim substantiation are baseline expectations for market access and enforcement resilience.

Clinical evaluation follows dental research standards and treats the product as an adjunct to hygiene and recall protocols. Primary endpoints include plaque indices and composition, salivary pH and buffering capacity, counts of Streptococcus mutans and key anaerobes, bleeding on probing and gingival indices, pocket-depth trends in maintenance cohorts, enamel surface microhardness or early-lesion arrest, and instrumented volatile sulfur compound reduction. Selected trials incorporate 16S rRNA profiling or qPCR for microbiome shifts, gas chromatography or electrochemical sensors for halitosis, quantitative light-induced fluorescence for demineralization assessment, and standardized diet controls to reduce confounding. Expected effect sizes are modest but clinically relevant when mechanism and dosage form match the risk phenotype and adherence is maintained.

Selection and procurement are mechanism- and form-led. Mucosal-contact formats are prioritized for microbiome modulation and halitosis control, while capsules and powders are efficient for mineral availability and systemic inflammatory tone. Labels declare probiotic colony-forming units at end-of-shelf-life with strain identifiers, mineral systems specify calcium and phosphate sources together with vitamin D and optional K₂, and omega-3 complexes state daily EPA+DHA equivalents and oxidation limits. Professional buyers request lot-level certificates of analysis referencing methods for potency and contaminants, stability evidence to labeled expiry under stated storage, and clinical substantiation packages aligning endpoints with labeled claims. Shipping and storage conditions are predefined, including temperature and humidity tolerances and allowable excursions.

Use and safety follow responsible supplementation principles. Dosing adheres to labeled instructions and age appropriateness; nutrient–drug interactions such as vitamin K with anticoagulants and high-dose zinc with copper balance are considered; probiotics are used cautiously in severely immunocompromised individuals. Allergen, pregnancy and lactation, and pediatric guidance is explicit. Products are integrated into regimens that include brushing, interdental cleaning, topical fluoride where indicated, diet counseling, and regular professional hygiene, and they are not positioned as substitutes for definitive periodontal or restorative therapies.

Selected research

Industry Growth & Trends

Global Oral Health Supplements Industry Growth and Trends Forecast to 2032

Market perspective

Oral health supplements are ingestible, non-prescription nutrition products intended to act within the oral cavity and along the oro-mucosal–systemic axis as an adjunct to evidence-based dental care. The category encompasses capsules, powders, liquids, orodispersible tablets, lozenges, chewing gums, and oromucosal films formulated to shift biofilm ecology toward commensal dominance, improve enamel mineral homeostasis, and modulate gingival–periodontal inflammatory tone. Topical cosmetics such as toothpastes and rinses are outside scope, and fluoride drugs or any product asserting disease treatment are regulated separately. In all major jurisdictions these products are governed under dietary or health-food frameworks with structure/function positioning and post-market surveillance rather than pre-market drug approval.

Formulation strategy is mechanism-led. Microbiome-directed designs use strain-identified probiotics or postbiotics with optional prebiotic substrates to suppress cariogenic and periodontopathogenic taxa, inhibit adhesion and co-aggregation, and stabilize intra-oral pH; dosage forms prioritize residence time through lozenges, gums, or thin films to maximize mucosal contact. Remineralization support raises salivary calcium-phosphate supersaturation and buffering capacity using bioavailable calcium and phosphate sources co-formulated with vitamin D and, where appropriate, vitamin K₂; arginine or xylitol may be included to leverage the arginine deiminase pathway and non-fermentable sweetening. Anti-inflammatory and antioxidant complexes, typically combining omega-3 EPA/DHA, coenzyme Q10, zinc, vitamin C, and selected polyphenols, aim to temper local mediators and support collagen synthesis in periodontal tissues. Halitosis control relies on odor-binding ions such as zinc and compatible microbiome modulators to reduce volatile sulfur compounds measured instrumentally.

Dosage-form engineering determines clinical yield. Orodispersible and mucoadhesive matrices based on HPMC, polycarbophil, or carbomers are tuned for wetting, controlled erosion, and adhesion to non-keratinized mucosa; oromucosal films are cast for uniform content, defined tear strength, and disintegration within targeted residence windows. Probiotic viability is protected through low-water-activity systems, glass-forming carriers, and oxygen control, with viable counts specified at end-of-shelf-life rather than at manufacture. Flavor and sweetening systems are chosen for dental compatibility, favoring xylitol or mannitol over fermentable sugars; compression, lubrication, and moisture management are balanced to prevent capping and to maintain friability in lozenges. Delivery performance is verified with appropriate disintegration and dissolution testing, residence-time studies in model saliva, and, for gums, mass-balance release methods.

Read the full market overview

Ingredient quality is defined to pharmacopeial or validated internal standards. Vitamins and minerals are declared by chemical form and potency; omega-3 concentrates specify EPA+DHA content together with oxidation indices; polyphenol sources are fingerprinted for marker compounds and screened for adulteration; probiotics are identified to strain by genetic or proteomic methods with contaminant screening and, where relevant, antibiotic-resistance profiling. Elemental contaminants such as arsenic, cadmium, lead, and mercury are controlled to stringent limits; microbial quality follows non-sterile supplement specifications with absence testing for relevant pathogens. Allergen and excipient declarations reflect regional labeling rules, including potential dairy or soy carriers in probiotic systems.

Manufacturing operates under current good manufacturing practice for dietary supplements. Quality-unit oversight, master manufacturing records with controlled changes, supplier qualification and full material traceability, validated analytical methods, in-process controls, and finished-product specifications for identity, strength, purity, and composition are mandatory. Out-of-specification investigations and corrective-and-preventive actions precede quality disposition. Stability programs combine accelerated and real-time studies to justify expiry; acceptance criteria cover potency retention, viable counts where applicable, organoleptics, and microbiological status. Packaging is selected for moisture and oxygen barrier performance appropriate to climate risk—Alu–Alu blisters, induction-sealed HDPE with desiccant canisters, or composite pouches with scavengers—supported by sorbent sizing calculations and transit simulations.

Claims, labeling, and surveillance are designed into the product at concept stage. In the United States, products carry substantiated structure/function claims such as “supports healthy gums,” bear the dietary-supplement disclaimer, and maintain serious adverse-event reporting; disease claims are excluded. In the European Union, supplements are defined under food-supplement law and all nutrition and health claims use authorized or qualified wording; novel ingredients may require novel-food clearance. In China, the category is managed as health foods with registration or filing and defined function catalogues; in Japan, many products follow FOSHU or Foods with Function Claims routes with pre-market notification and public evidence summaries. Across markets, truthful labeling, transparent quantitation of actives, and documented claim substantiation are baseline expectations for market access and enforcement resilience.

Clinical evaluation follows dental research standards and treats the product as an adjunct to hygiene and recall protocols. Primary endpoints include plaque indices and composition, salivary pH and buffering capacity, counts of Streptococcus mutans and key anaerobes, bleeding on probing and gingival indices, pocket-depth trends in maintenance cohorts, enamel surface microhardness or early-lesion arrest, and instrumented volatile sulfur compound reduction. Selected trials incorporate 16S rRNA profiling or qPCR for microbiome shifts, gas chromatography or electrochemical sensors for halitosis, quantitative light-induced fluorescence for demineralization assessment, and standardized diet controls to reduce confounding. Expected effect sizes are modest but clinically relevant when mechanism and dosage form match the risk phenotype and adherence is maintained.

Selection and procurement are mechanism- and form-led. Mucosal-contact formats are prioritized for microbiome modulation and halitosis control, while capsules and powders are efficient for mineral availability and systemic inflammatory tone. Labels declare probiotic colony-forming units at end-of-shelf-life with strain identifiers, mineral systems specify calcium and phosphate sources together with vitamin D and optional K₂, and omega-3 complexes state daily EPA+DHA equivalents and oxidation limits. Professional buyers request lot-level certificates of analysis referencing methods for potency and contaminants, stability evidence to labeled expiry under stated storage, and clinical substantiation packages aligning endpoints with labeled claims. Shipping and storage conditions are predefined, including temperature and humidity tolerances and allowable excursions.

Use and safety follow responsible supplementation principles. Dosing adheres to labeled instructions and age appropriateness; nutrient–drug interactions such as vitamin K with anticoagulants and high-dose zinc with copper balance are considered; probiotics are used cautiously in severely immunocompromised individuals. Allergen, pregnancy and lactation, and pediatric guidance is explicit. Products are integrated into regimens that include brushing, interdental cleaning, topical fluoride where indicated, diet counseling, and regular professional hygiene, and they are not positioned as substitutes for definitive periodontal or restorative therapies.

The global Oral Health Supplements market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Oral Health Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Oral Health Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

The Asia Pacific market for Oral Health Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral Health Supplements include BioGaia AB, Sunstar Suisse SA, Life Extension, Swisse Wellness, NOW Foods, Kaneka AB-Biotics, Blis Technologies, WonderLab and Hyperbiotics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Oral Health Supplements market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oral Health Supplements market size, estimates, and forecasts are presented in terms of sales volume (tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oral Health Supplements market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oral Health Supplements.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Oral Health Supplements market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oral Health Supplements Market by Company

BioGaia AB

Sunstar Suisse SA

Life Extension

Swisse Wellness

NOW Foods

Kaneka AB-Biotics

Blis Technologies

WonderLab

Hyperbiotics

Hager Pharma

ProBiora Health

JEX Co., Ltd

Dentis Co., Ltd

Oral Health Supplements Segment by Type

Lozenges

Drops

Powder

Strips and Gums

Oral Health Supplements Segment by Application

Daily Care

Perio Adjunct

Halitosis

Caries and Orthodontic

Xerostomia

Oral Health Supplements Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Health Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Health Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Health Supplements.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral Health Supplements manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Oral Health Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Lozenges Table 2. Major Company of Drops Table 3. Major Company of Powder Table 4. Major Company of Strips and Gums Table 5. Global Oral Health Supplements Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Oral Health Supplements Sales by Type (2021-2026) & (tons) Table 7. Global Oral Health Supplements Sales Market Share in Volume by Type (2021-2026) Table 8. Global Oral Health Supplements Sales by Type (2021-2026) & (US$ Million) Table 9. Global Oral Health Supplements Sales Market Share in Value by Type (2021-2026) Table 10. Global Oral Health Supplements Price by Type (2021-2026) & (USD/kg) Table 11. Global Oral Health Supplements Sales by Type (2027-2032) & (tons) Table 12. Global Oral Health Supplements Sales Market Share in Volume by Type (2027-2032) Table 13. Global Oral Health Supplements Sales by Type (2027-2032) & (US$ Million) Table 14. Global Oral Health Supplements Sales Market Share in Value by Type (2027-2032) Table 15. Global Oral Health Supplements Price by Type (2027-2032) & (USD/kg) Table 16. North America Oral Health Supplements Sales by Type (2021-2026) & (tons) Table 17. North America Oral Health Supplements Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Oral Health Supplements Sales by Type (2021-2026) & (tons) Table 19. Europe Oral Health Supplements Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Oral Health Supplements Sales by Type (2021-2026) & (tons) Table 21. Asia-Pacific Oral Health Supplements Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Oral Health Supplements Sales by Type (2021-2026) & (tons) Table 23. Latin America Oral Health Supplements Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Oral Health Supplements Sales by Type (2021-2026) & (tons) Table 25. Middle East and Africa Oral Health Supplements Sales by Type (2021-2026) & (US$ Million) Table 26. Oral Health Supplements Industry Trends Table 27. Oral Health Supplements Industry Drivers Table 28. Oral Health Supplements Industry Opportunities and Challenges Table 29. Oral Health Supplements Industry Restraints Table 30. Global Oral Health Supplements Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Oral Health Supplements Revenue Market Share by Company (2021-2026) Table 32. Global Oral Health Supplements Sales by Company (2021-2026) & (tons) Table 33. Global Oral Health Supplements Sales Share by Company (2021-2026) Table 34. Global Oral Health Supplements Market Price by Company (2021-2026) & (USD/kg) Table 35. Global Oral Health Supplements Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Oral Health Supplements Major Company Production Sites and Headquarters Table 37. Global Oral Health Supplements Company, Product Type & Application Table 38. Global Oral Health Supplements Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Oral Health Supplements by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Oral Health Supplements Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Oral Health Supplements Sales by Region (2021-2026) & (tons) Table 43. Global Oral Health Supplements Sales Market Share in Volume by Region (2021-2026) Table 44. Global Oral Health Supplements Sales by Region (2021-2026) & (US$ Million) Table 45. Global Oral Health Supplements Sales Market Share in Value by Region (2021-2026) Table 46. Global Oral Health Supplements Sales (tons), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 47. Global Oral Health Supplements Sales by Region (2027-2032) & (tons) Table 48. Global Oral Health Supplements Sales Market Share in Volume by Region (2027-2032) Table 49. Global Oral Health Supplements Sales by Region (2027-2032) & (US$ Million) Table 50. Global Oral Health Supplements Sales Market Share in Value by Region (2027-2032) Table 51. Global Oral Health Supplements Sales (tons), Value (US$ Million), Price (USD/kg) and Gross Margin (2027-2032) Table 52. Global Oral Health Supplements Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Oral Health Supplements Sales by Application (2021-2026) & (tons) Table 54. Global Oral Health Supplements Sales Market Share in Volume by Application (2021-2026) Table 55. Global Oral Health Supplements Sales by Application (2021-2026) & (US$ Million) Table 56. Global Oral Health Supplements Sales Market Share in Value by Application (2021-2026) Table 57. Global Oral Health Supplements Price by Application (2021-2026) & (USD/kg) Table 58. Global Oral Health Supplements Sales by Application (2027-2032) & (tons) Table 59. Global Oral Health Supplements Sales Market Share in Volume by Application (2027-2032) Table 60. Global Oral Health Supplements Sales by Application (2027-2032) & (US$ Million) Table 61. Global Oral Health Supplements Sales Market Share in Value by Application (2027-2032) Table 62. Global Oral Health Supplements Price by Application (2027-2032) & (USD/kg) Table 63. North America Oral Health Supplements Sales by Application (2021-2026) & (tons) Table 64. North America Oral Health Supplements Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Oral Health Supplements Sales by Application (2021-2026) & (tons) Table 66. Europe Oral Health Supplements Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Oral Health Supplements Sales by Application (2021-2026) & (tons) Table 68. Asia-Pacific Oral Health Supplements Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Oral Health Supplements Sales by Application (2021-2026) & (tons) Table 70. Latin America Oral Health Supplements Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Oral Health Supplements Sales by Application (2021-2026) & (tons) Table 72. Middle East and Africa Oral Health Supplements Sales by Application (2021-2026) & (US$ Million) Table 73. BioGaia AB Company Information Table 74. BioGaia AB Business Overview Table 75. BioGaia AB Oral Health Supplements Sales (tons), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 76. BioGaia AB Oral Health Supplements Product Portfolio Table 77. BioGaia AB Recent Development Table 78. Sunstar Suisse SA Company Information Table 79. Sunstar Suisse SA Business Overview Table 80. Sunstar Suisse SA Oral Health Supplements Sales (tons), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 81. Sunstar Suisse SA Oral Health Supplements Product Portfolio Table 82. Sunstar Suisse SA Recent Development Table 83. Life Extension Company Information Table 84. Life Extension Business Overview Table 85. Life Extension Oral Health Supplements Sales (tons), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 86. Life Extension Oral Health Supplements Product Portfolio Table 87. Life Extension Recent Development Table 88. Swisse Wellness Company Information Table 89. Swisse Wellness Business Overview Table 90. Swisse Wellness Oral Health Supplements Sales (tons), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 91. Swisse Wellness Oral Health Supplements Product Portfolio Table 92. Swisse Wellness Recent Development Table 93. NOW Foods Company Information Table 94. NOW Foods Business Overview Table 95. NOW Foods Oral Health Supplements Sales (tons), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 96. NOW Foods Oral Health Supplements Product Portfolio Table 97. NOW Foods Recent Development Table 98. Kaneka AB-Biotics Company Information Table 99. Kaneka AB-Biotics Business Overview Table 100. Kaneka AB-Biotics Oral Health Supplements Sales (tons), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 101. Kaneka AB-Biotics Oral Health Supplements Product Portfolio Table 102. Kaneka AB-Biotics Recent Development Table 103. Blis Technologies Company Information Table 104. Blis Technologies Business Overview Table 105. Blis Technologies Oral Health Supplements Sales (tons), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 106. Blis Technologies Oral Health Supplements Product Portfolio Table 107. Blis Technologies Recent Development Table 108. WonderLab Company Information Table 109. WonderLab Business Overview Table 110. WonderLab Oral Health Supplements Sales (tons), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 111. WonderLab Oral Health Supplements Product Portfolio Table 112. WonderLab Recent Development Table 113. Hyperbiotics Company Information Table 114. Hyperbiotics Business Overview Table 115. Hyperbiotics Oral Health Supplements Sales (tons), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 116. Hyperbiotics Oral Health Supplements Product Portfolio Table 117. Hyperbiotics Recent Development Table 118. Hager Pharma Company Information Table 119. Hager Pharma Business Overview Table 120. Hager Pharma Oral Health Supplements Sales (tons), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 121. Hager Pharma Oral Health Supplements Product Portfolio Table 122. Hager Pharma Recent Development Table 123. ProBiora Health Company Information Table 124. ProBiora Health Business Overview Table 125. ProBiora Health Oral Health Supplements Sales (tons), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 126. ProBiora Health Oral Health Supplements Product Portfolio Table 127. ProBiora Health Recent Development Table 128. JEX Co., Ltd Company Information Table 129. JEX Co., Ltd Business Overview Table 130. JEX Co., Ltd Oral Health Supplements Sales (tons), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 131. JEX Co., Ltd Oral Health Supplements Product Portfolio Table 132. JEX Co., Ltd Recent Development Table 133. Dentis Co., Ltd Company Information Table 134. Dentis Co., Ltd Business Overview Table 135. Dentis Co., Ltd Oral Health Supplements Sales (tons), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 136. Dentis Co., Ltd Oral Health Supplements Product Portfolio Table 137. Dentis Co., Ltd Recent Development Table 138. North America Oral Health Supplements Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 139. North America Oral Health Supplements Sales by Country (2021-2026) & (tons) Table 140. North America Oral Health Supplements Sales Market Share by Country (2021-2026) Table 141. North America Oral Health Supplements Sales Forecast by Country (2027-2032) & (tons) Table 142. North America Oral Health Supplements Sales Market Share Forecast by Country (2027-2032) Table 143. North America Oral Health Supplements Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. North America Oral Health Supplements Market Size by Country (2021-2026) & (US$ Million) Table 145. North America Oral Health Supplements Market Share by Country (2021-2026) Table 146. North America Oral Health Supplements Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. North America Oral Health Supplements Market Share Forecast by Country (2027-2032) Table 148. Europe Oral Health Supplements Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 149. Europe Oral Health Supplements Sales by Country (2021-2026) & (tons) Table 150. Europe Oral Health Supplements Sales Market Share by Country (2021-2026) Table 151. Europe Oral Health Supplements Sales Forecast by Country (2027-2032) & (tons) Table 152. Europe Oral Health Supplements Sales Market Share Forecast by Country (2027-2032) Table 153. Europe Oral Health Supplements Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Oral Health Supplements Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Oral Health Supplements Market Share by Country (2021-2026) Table 156. Europe Oral Health Supplements Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Oral Health Supplements Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Oral Health Supplements Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Oral Health Supplements Sales by Country (2021-2026) & (tons) Table 160. Asia-Pacific Oral Health Supplements Sales Market Share by Country (2021-2026) Table 161. Asia-Pacific Oral Health Supplements Sales Forecast by Country (2027-2032) & (tons) Table 162. Asia-Pacific Oral Health Supplements Sales Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Oral Health Supplements Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Oral Health Supplements Market Size by Country (2021-2026) & (US$ Million) Table 165. Asia-Pacific Oral Health Supplements Market Share by Country (2021-2026) Table 166. Asia-Pacific Oral Health Supplements Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Asia-Pacific Oral Health Supplements Market Share Forecast by Country (2027-2032) Table 168. Latin America Oral Health Supplements Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 169. Latin America Oral Health Supplements Sales by Country (2021-2026) & (tons) Table 170. Latin America Oral Health Supplements Sales Market Share by Country (2021-2026) Table 171. Latin America Oral Health Supplements Sales Forecast by Country (2027-2032) & (tons) Table 172. Latin America Oral Health Supplements Sales Market Share Forecast by Country (2027-2032) Table 173. Latin America Oral Health Supplements Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Latin America Oral Health Supplements Market Size by Country (2021-2026) & (US$ Million) Table 175. Latin America Oral Health Supplements Market Share by Country (2021-2026) Table 176. Latin America Oral Health Supplements Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Latin America Oral Health Supplements Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa Oral Health Supplements Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa Oral Health Supplements Sales by Country (2021-2026) & (tons) Table 180. Middle East and Africa Oral Health Supplements Sales Market Share by Country (2021-2026) Table 181. Middle East and Africa Oral Health Supplements Sales Forecast by Country (2027-2032) & (tons) Table 182. Middle East and Africa Oral Health Supplements Sales Market Share Forecast by Country (2027-2032) Table 183. Middle East and Africa Oral Health Supplements Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Middle East and Africa Oral Health Supplements Market Size by Country (2021-2026) & (US$ Million) Table 185. Middle East and Africa Oral Health Supplements Market Share by Country (2021-2026) Table 186. Middle East and Africa Oral Health Supplements Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Middle East and Africa Oral Health Supplements Market Share Forecast by Country (2027-2032) Table 188. Key Raw Materials Table 189. Raw Materials Key Suppliers Table 190. Oral Health Supplements Distributors List Table 191. Oral Health Supplements Customers List Table 192. Research Programs/Design for This Report Table 193. Authors List of This Report Table 194. Secondary Sources Table 195. Primary Sources List of Figures Figure 1. Oral Health Supplements Image Figure 2. Global Oral Health Supplements Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Health Supplements Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral Health Supplements Sales (2021-2032) & (tons) Figure 5. Lozenges Image Figure 6. Global Lozenges Sales YoY Growth (2021-2032) & (tons) Figure 7. Drops Image Figure 8. Global Drops Sales YoY Growth (2021-2032) & (tons) Figure 9. Powder Image Figure 10. Global Powder Sales YoY Growth (2021-2032) & (tons) Figure 11. Strips and Gums Image Figure 12. Global Strips and Gums Sales YoY Growth (2021-2032) & (tons) Figure 13. Global Oral Health Supplements Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Oral Health Supplements Market Share by Type 2025 VS 2032 Figure 15. North America Oral Health Supplements Sales Market Share in Volume by Type in 2025 Figure 16. North America Oral Health Supplements Sales Market Share in Value by Type in 2025 Figure 17. Europe Oral Health Supplements Sales Market Share in Volume by Type in 2025 Figure 18. Europe Oral Health Supplements Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Oral Health Supplements Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Oral Health Supplements Sales Market Share in Value by Type in 2025 Figure 21. Latin America Oral Health Supplements Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Oral Health Supplements Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Oral Health Supplements Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Oral Health Supplements Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Oral Health Supplements Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Daily Care Image Figure 28. Global Daily Care Sales YoY Growth (2021-2032) & (tons) Figure 29. Perio Adjunct Image Figure 30. Global Perio Adjunct Sales YoY Growth (2021-2032) & (tons) Figure 31. Halitosis Image Figure 32. Global Halitosis Sales YoY Growth (2021-2032) & (tons) Figure 33. Caries and Orthodontic Image Figure 34. Global Caries and Orthodontic Sales YoY Growth (2021-2032) & (tons) Figure 35. Xerostomia Image Figure 36. Global Xerostomia Sales YoY Growth (2021-2032) & (tons) Figure 37. Global Oral Health Supplements Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Oral Health Supplements Market Share by Application 2025 VS 2032 Figure 39. North America Oral Health Supplements Sales Market Share in Volume by Application in 2025 Figure 40. North America Oral Health Supplements Sales Market Share in Value by Application in 2025 Figure 41. Europe Oral Health Supplements Sales Market Share in Volume by Application in 2025 Figure 42. Europe Oral Health Supplements Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Oral Health Supplements Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Oral Health Supplements Sales Market Share in Value by Application in 2025 Figure 45. Latin America Oral Health Supplements Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Oral Health Supplements Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Oral Health Supplements Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Oral Health Supplements Sales Market Share in Value by Application in 2025 Figure 49. North America Oral Health Supplements Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 50. North America Oral Health Supplements Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Oral Health Supplements Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Oral Health Supplements Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Oral Health Supplements Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 54. Europe Oral Health Supplements Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Oral Health Supplements Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Oral Health Supplements Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Oral Health Supplements Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 58. Asia-Pacific Oral Health Supplements Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Oral Health Supplements Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Oral Health Supplements Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Oral Health Supplements Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 62. Latin America Oral Health Supplements Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Oral Health Supplements Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Oral Health Supplements Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Oral Health Supplements Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 66. Middle East and Africa Oral Health Supplements Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Oral Health Supplements Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Oral Health Supplements Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Oral Health Supplements Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Oral Health Supplements Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Lozenges
  • Drops
  • Powder
  • Strips and Gums
Applications
  • Daily Care
  • Perio Adjunct
  • Halitosis
  • Caries and Orthodontic
  • Xerostomia
Companies covered
  • BioGaia AB
  • Sunstar Suisse SA
  • Life Extension
  • Swisse Wellness
  • NOW Foods
  • Kaneka AB-Biotics
  • Blis Technologies
  • WonderLab
  • Hyperbiotics
  • Hager Pharma
  • ProBiora Health
  • JEX Co., Ltd
  • Dentis Co., Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oral Health Supplements Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Oral Health Supplements Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Oral Health Supplements Market by Type
  6. 1.3.1 Lozenges
  7. 1.3.2 Drops
  8. 1.3.3 Powder
  9. 1.3.4 Strips and Gums
  10. 1.4 Global Oral Health Supplements Market Size by Type
  11. 1.4.1 Global Oral Health Supplements Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Oral Health Supplements Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Oral Health Supplements Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Oral Health Supplements Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Oral Health Supplements Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Oral Health Supplements Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Oral Health Supplements Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Oral Health Supplements Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Oral Health Supplements Industry Trends
  2. 2.2 Oral Health Supplements Industry Drivers
  3. 2.3 Oral Health Supplements Industry Opportunities and Challenges
  4. 2.4 Oral Health Supplements Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Oral Health Supplements Revenue (2021-2026)
  2. 3.2 Global Top Players by Oral Health Supplements Sales (2021-2026)
  3. 3.3 Global Top Players by Oral Health Supplements Price (2021-2026)
  4. 3.4 Global Oral Health Supplements Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral Health Supplements Major Company Production Sites & Headquarters
  6. 3.6 Global Oral Health Supplements Company, Product Type & Application
  7. 3.7 Global Oral Health Supplements Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral Health Supplements Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral Health Supplements Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral Health Supplements Tier 1, Tier 2, and Tier 3
4 Oral Health Supplements Regional Status and Outlook
  1. 4.1 Global Oral Health Supplements Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Oral Health Supplements Historic Market Size by Region
  3. 4.2.1 Global Oral Health Supplements Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Oral Health Supplements Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Oral Health Supplements Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Oral Health Supplements Forecasted Market Size by Region
  7. 4.3.1 Global Oral Health Supplements Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Oral Health Supplements Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Oral Health Supplements Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oral Health Supplements by Application
  1. 5.1 Oral Health Supplements Market by Application
  2. 5.1.1 Daily Care
  3. 5.1.2 Perio Adjunct
  4. 5.1.3 Halitosis
  5. 5.1.4 Caries and Orthodontic
  6. 5.1.5 Xerostomia
  7. 5.2 Global Oral Health Supplements Market Size by Application
  8. 5.2.1 Global Oral Health Supplements Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Oral Health Supplements Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Oral Health Supplements Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Oral Health Supplements Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Oral Health Supplements Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Oral Health Supplements Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Oral Health Supplements Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Oral Health Supplements Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 BioGaia AB
  2. 6.1.1 BioGaia AB Company Information
  3. 6.1.2 BioGaia AB Business Overview
  4. 6.1.3 BioGaia AB Oral Health Supplements Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 BioGaia AB Oral Health Supplements Product Portfolio
  6. 6.1.5 BioGaia AB Recent Developments
  7. 6.2 Sunstar Suisse SA
  8. 6.2.1 Sunstar Suisse SA Company Information
  9. 6.2.2 Sunstar Suisse SA Business Overview
  10. 6.2.3 Sunstar Suisse SA Oral Health Supplements Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sunstar Suisse SA Oral Health Supplements Product Portfolio
  12. 6.2.5 Sunstar Suisse SA Recent Developments
  13. 6.3 Life Extension
  14. 6.3.1 Life Extension Company Information
  15. 6.3.2 Life Extension Business Overview
  16. 6.3.3 Life Extension Oral Health Supplements Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Life Extension Oral Health Supplements Product Portfolio
  18. 6.3.5 Life Extension Recent Developments
  19. 6.4 Swisse Wellness
  20. 6.4.1 Swisse Wellness Company Information
  21. 6.4.2 Swisse Wellness Business Overview
  22. 6.4.3 Swisse Wellness Oral Health Supplements Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Swisse Wellness Oral Health Supplements Product Portfolio
  24. 6.4.5 Swisse Wellness Recent Developments
  25. 6.5 NOW Foods
  26. 6.5.1 NOW Foods Company Information
  27. 6.5.2 NOW Foods Business Overview
  28. 6.5.3 NOW Foods Oral Health Supplements Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 NOW Foods Oral Health Supplements Product Portfolio
  30. 6.5.5 NOW Foods Recent Developments
  31. 6.6 Kaneka AB-Biotics
  32. 6.6.1 Kaneka AB-Biotics Company Information
  33. 6.6.2 Kaneka AB-Biotics Business Overview
  34. 6.6.3 Kaneka AB-Biotics Oral Health Supplements Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Kaneka AB-Biotics Oral Health Supplements Product Portfolio
  36. 6.6.5 Kaneka AB-Biotics Recent Developments
  37. 6.7 Blis Technologies
  38. 6.7.1 Blis Technologies Company Information
  39. 6.7.2 Blis Technologies Business Overview
  40. 6.7.3 Blis Technologies Oral Health Supplements Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Blis Technologies Oral Health Supplements Product Portfolio
  42. 6.7.5 Blis Technologies Recent Developments
  43. 6.8 WonderLab
  44. 6.8.1 WonderLab Company Information
  45. 6.8.2 WonderLab Business Overview
  46. 6.8.3 WonderLab Oral Health Supplements Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 WonderLab Oral Health Supplements Product Portfolio
  48. 6.8.5 WonderLab Recent Developments
  49. 6.9 Hyperbiotics
  50. 6.9.1 Hyperbiotics Company Information
  51. 6.9.2 Hyperbiotics Business Overview
  52. 6.9.3 Hyperbiotics Oral Health Supplements Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Hyperbiotics Oral Health Supplements Product Portfolio
  54. 6.9.5 Hyperbiotics Recent Developments
  55. 6.10 Hager Pharma
  56. 6.10.1 Hager Pharma Company Information
  57. 6.10.2 Hager Pharma Business Overview
  58. 6.10.3 Hager Pharma Oral Health Supplements Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Hager Pharma Oral Health Supplements Product Portfolio
  60. 6.10.5 Hager Pharma Recent Developments
  61. 6.11 ProBiora Health
  62. 6.11.1 ProBiora Health Company Information
  63. 6.11.2 ProBiora Health Business Overview
  64. 6.11.3 ProBiora Health Oral Health Supplements Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 ProBiora Health Oral Health Supplements Product Portfolio
  66. 6.11.5 ProBiora Health Recent Developments
  67. 6.12 JEX Co., Ltd
  68. 6.12.1 JEX Co., Ltd Company Information
  69. 6.12.2 JEX Co., Ltd Business Overview
  70. 6.12.3 JEX Co., Ltd Oral Health Supplements Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 JEX Co., Ltd Oral Health Supplements Product Portfolio
  72. 6.12.5 JEX Co., Ltd Recent Developments
  73. 6.13 Dentis Co., Ltd
  74. 6.13.1 Dentis Co., Ltd Company Information
  75. 6.13.2 Dentis Co., Ltd Business Overview
  76. 6.13.3 Dentis Co., Ltd Oral Health Supplements Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Dentis Co., Ltd Oral Health Supplements Product Portfolio
  78. 6.13.5 Dentis Co., Ltd Recent Developments
7 North America by Country
  1. 7.1 North America Oral Health Supplements Sales by Country
  2. 7.1.1 North America Oral Health Supplements Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Oral Health Supplements Sales by Country (2021-2026)
  4. 7.1.3 North America Oral Health Supplements Sales Forecast by Country (2027-2032)
  5. 7.2 North America Oral Health Supplements Market Size by Country
  6. 7.2.1 North America Oral Health Supplements Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Oral Health Supplements Market Size by Country (2021-2026)
  8. 7.2.3 North America Oral Health Supplements Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Oral Health Supplements Sales by Country
  2. 8.1.1 Europe Oral Health Supplements Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Oral Health Supplements Sales by Country (2021-2026)
  4. 8.1.3 Europe Oral Health Supplements Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Oral Health Supplements Market Size by Country
  6. 8.2.1 Europe Oral Health Supplements Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Oral Health Supplements Market Size by Country (2021-2026)
  8. 8.2.3 Europe Oral Health Supplements Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Oral Health Supplements Sales by Country
  2. 9.1.1 Asia-Pacific Oral Health Supplements Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Oral Health Supplements Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Oral Health Supplements Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Oral Health Supplements Market Size by Country
  6. 9.2.1 Asia-Pacific Oral Health Supplements Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Oral Health Supplements Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Oral Health Supplements Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Oral Health Supplements Sales by Country
  2. 10.1.1 South America Oral Health Supplements Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Oral Health Supplements Sales by Country (2021-2026)
  4. 10.1.3 South America Oral Health Supplements Sales Forecast by Country (2027-2032)
  5. 10.2 South America Oral Health Supplements Market Size by Country
  6. 10.2.1 South America Oral Health Supplements Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Oral Health Supplements Market Size by Country (2021-2026)
  8. 10.2.3 South America Oral Health Supplements Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Oral Health Supplements Sales by Country
  2. 11.1.1 Middle East and Africa Oral Health Supplements Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Oral Health Supplements Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Oral Health Supplements Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Oral Health Supplements Market Size by Country
  6. 11.2.1 Middle East and Africa Oral Health Supplements Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Oral Health Supplements Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Oral Health Supplements Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Oral Health Supplements Value Chain Analysis
  2. 12.1.1 Oral Health Supplements Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Oral Health Supplements Production Mode & Process
  7. 12.2 Oral Health Supplements Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Oral Health Supplements Distributors
  10. 12.2.3 Oral Health Supplements Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research